- Home
- LUCD vs RPT Comparison
LUCD vs RPT Comparison
Compare LUCD & RPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- RPT
- Stock Information
- Founded
- LUCD 2018
- RPT 2014
- Country
- LUCD United States
- RPT United States
- Employees
- LUCD N/A
- RPT N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RPT
- Sector
- LUCD Health Care
- RPT
- Exchange
- LUCD Nasdaq
- RPT NYSE
- Market Cap
- LUCD 112.5M
- RPT 121.7M
- IPO Year
- LUCD 2021
- RPT N/A
- Fundamental
- Price
- LUCD $1.11
- RPT $2.67
- Analyst Decision
- LUCD Strong Buy
- RPT Strong Buy
- Analyst Count
- LUCD 4
- RPT 1
- Target Price
- LUCD $3.94
- RPT $4.00
- AVG Volume (30 Days)
- LUCD 1.5M
- RPT 372.9K
- Earning Date
- LUCD 08-11-2025
- RPT 07-24-2025
- Dividend Yield
- LUCD N/A
- RPT 8.99%
- EPS Growth
- LUCD N/A
- RPT N/A
- EPS
- LUCD N/A
- RPT N/A
- Revenue
- LUCD $4,173,000.00
- RPT $8,096,000.00
- Revenue This Year
- LUCD $49.70
- RPT N/A
- Revenue Next Year
- LUCD $198.20
- RPT $19.21
- P/E Ratio
- LUCD N/A
- RPT N/A
- Revenue Growth
- LUCD 39.89
- RPT N/A
- 52 Week Low
- LUCD $0.72
- RPT $2.29
- 52 Week High
- LUCD $1.80
- RPT $3.78
- Technical
- Relative Strength Index (RSI)
- LUCD 44.54
- RPT N/A
- Support Level
- LUCD $1.08
- RPT N/A
- Resistance Level
- LUCD $1.14
- RPT N/A
- Average True Range (ATR)
- LUCD 0.07
- RPT 0.00
- MACD
- LUCD 0.00
- RPT 0.00
- Stochastic Oscillator
- LUCD 41.03
- RPT 0.00
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About RPT RITHM PROPERTY TRUST INC
Rithm Property Trust Inc is a real estate investment trust (REIT) externally managed by an affiliate of Rithm Capital Corp. (Rithm). The group is embarking on a new commercial real estate-focused investment. Its tailored approach to investment management seeks to generate attractive risk-adjusted returns for stockholders over the long term through dividends and capital appreciation.